Access to medical cannabis in Australia

24 January 2019

This step by step guide has been specifically designed to help patients understand how to access medical cannabis in Australia.

Medical cannabis in Australia is almost universally classified as an unapproved product and is not a registered prescription medicine. Despite this, patients can still access unregistered medicinal cannabis products via the following three access pathways:

  • Special access scheme (SAS)
  • Authorised prescribers
  • Clinical trials

Special Access Scheme (SAS) Category B is the most common and quickest pathway a medical practitioner can take to prescribe a medicinal cannabis product to a single patient. This document focuses on this process only. Practitioners can contact Little Green Pharma directly to discuss other options such as Authorised Prescriber pathway.

Medical Cannabis is not a first line treatment

Before you consider this treatment option, you should be aware that the Therapeutic Goods Administration (TGA) advises medical cannabis is not a first line treatment. This means cannabinoid therapy can only be used after standard treatments have been unsuccessful or caused unacceptable adverse effects, except in the case of patients in palliative care.

Please note this should not be considered as medical or regulatory advice and to also read our Terms of Use.

How to access to medical cannabis in Australia

STEP 1: Doctor consultation

It is recommended as a first step patients see their usual treating doctor, GP or specialist.

Please note: this needs to be an Australian-registered medical practitioner with appropriate qualifications and/or expertise for the condition requiring treatment e.g. for a patient suffering from Chronic pain, generally only a specialist or GP with expertise in treating this condition can make an application.

Your current treating medical practitioner should have a good understanding of your medical conditions AND access to your medical records (these records may need to be submitted if an application is made to the TGA).

For more information on:

  • how to discuss medical cannabis with your doctor,
  • what to do if your doctor(s) are/aren’t confident or willing to consider medical cannabis,
  • how to find an alternative doctor,

Please visit the FAQ page ‘Are doctors for medical cannabis?’

STEP 2: Product consideration

If your medical practitioner decides that cannabinoid therapy is an appropriate treatment they will then need to determine exactly which product is suitable. They are likely to consider the following;

  • product availability by supplier;
  • the ongoing costs to patient;
  • a dispensing pharmacy and
  • if it is a ‘Schedule 4’ medicine (Prescription Only) or ‘Schedule 8’ medicine (Controlled Drug) as the approval process and product delivery can differ between the two.

Product choice is the responsibility of the doctor and they’ll research and compare products to find which best fits your condition and circumstances. TGA applications require documentation confirming the product meets the safety and quality requirements set out in Therapeutic Goods Order No 93 (TGO93). This information is normally supplied to the TGA by the manufacturer and this is something Little Green Pharma can confirm with practitioners.

Little Green Pharma products are currently all classified as Schedule 8 due to the fact they contain the cannabinoid THC.

Product Information
Detailed product information, including the price of products, is available only to medical practitioners and can be obtained by contacting Little Green Pharma directly on (08) 6280 0050 or email medical@lgpharma.com.au.

STEP 3: Application to TGA and State Health

With a patient’s consent, practitioners can apply for federal and state approval via the SAS B pathway mentioned earlier.

In order to apply for access to medical cannabis a medical practitioner to will need to meet the TGA’s requirements and:

  • have confirmed your medical condition and relevant medical history,
  • submit documentation outlining which medications for your condition have been prescribed and are not working or have adverse effects,
  • submit evidence or research showing therapeutic benefit from the use of medical cannabis in patients with a similar medical condition.

Read more information regarding the TGA and how to access medicinal cannabis.

Who can apply?

This varies depending on the state/territory. In most states, a GP can initiate an application. In some other states, like in WA, GPs can apply but currently require a Specialist’s support or expertise in the area for which the medication is being prescribed. Specialist support is required if a practitioner does not have the relevant expertise or qualification to treat the patient’s condition.

Please note:
SAS B applications will ask if the medical practitioner making the application is the patient’s usual doctor.

It is preferable for patients to be prescribed medical cannabis by their regular medical practitioner.

Does your doctor need assistance with the application?

Practitioners can find assistance compiling an application for Little Green Pharma products by contacting us directly on (08) 6280 0050 or email medical@lgpharma.com.au.

 

STEP 4: TGA Approval

Under current legislation if you are located in NSW, Victoria, Queensland, WA, SA or NT, upon receiving combined TGA & State approval a practitioner can then prescribe medicinal cannabis to the patient – Go to Step 6.
For Schedule 8 medicines, in the ACT and Tasmania practitioners must take a second step to obtain prescribing approval which is to submit a second application to the state health department – Go to Step 5.

 

STEP 5: Separate State / Territory Approval  (for TAS & ACT)

Each Australian State and Territory has different requirements for patients accessing medical cannabis depending on which schedule listing the medical cannabis products are classified under (Schedule 4 or 8). Little Green Pharma products are currently all classified as Schedule 8 due to the fact they contain the cannabinoid THC.

Schedule 8: Upon approval from the TGA, the doctor will receive an approval certificate that must be provided as part of a separate application to the relevant State Health Department.

Schedule 4: no State Health Department approvals are required, except in Queensland.

Read more about access to medicinal cannabis in the ACT or Tasmania.

STEP 6: Patient Access

Upon approval from both TGA and State Health Department, a patient will receive their script and approvals for medical cannabis which needs to be presented at their choice of pharmacy. The relevant Health Department approvals will need to sent to the wholesaler by the pharmacy. Wholesalers then release their product to the pharmacy who will dispense this to the patient.
Hospital pharmacies may supply for in-patients on a copy of a medication chart order.

Please note: A pharmacist can dispense product to a patient only on receipt of an original prescription, as well as a copy of the TGA and State Health approvals (if relevant).

If you are based in Western Australia and seeking Little Green Pharma products:

Please contact Oxford Compounding on:
Ph (08) 9225 9400
E: jason@compoundingonoxford.com.au

Patients can pick up their product from North Perth or have this posted directly to them for an additional $20.

For all other states & territories:

Please ask your pharmacist to contact Health House on:
Ph: (08) 9444 2444
E: info@healthhouse.com.au

Want to know more?

Little Green Pharma has sponsored a site greenchoices.com.au with detailed information on eligibility for medicinal cannabis and how this new treatment works across a range of conditions.

Visit GreenChoices to learn about medicinal cannabis in Australia.

Back to news